Abiopharma

🔍 Kalowski Lee (Executive)

Company: Q32 Bio Inc. (QTTB)

Report Date: 2025-08-26

Detailed Transactions and Holdings:

• Sold 4,240 shares of Common Stock at $1.801 per share (Direct)
  Date: 2025-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 49,010.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
• F2: The price reported is a weighted average price. The securities were sold in multiple transactions over two consecutive trading days, at per share prices ranging from $1.81 to $1.96 and $1.73 to $1.83, respectively. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 2.